Bladder cancer
CURRENT OPINION IN ONCOLOGY (2008)
期刊
CURRENT OPINION IN ONCOLOGY
卷 20, 期 3, 页码 307-314出版社
LIPPINCOTT WILLIAMS & WILKINS
关键词
类别
作者
我是这篇论文的作者
推荐
Nanotechnology in Bladder Cancer: Diagnosis and Treatment
Mahmood Barani, Seyedeh Maryam Hosseinikhah, Abbas Rahdar, Leila Farhoudi, Rabia Arshad, Magali Cucchiarini, Sadanand Pandey
CANCERS (2021)
Application of nanotechnology in the diagnosis and treatment of bladder cancer
Yadong Xu, Cheng Luo, Jieqiong Wang, Lingwu Chen, Junxing Chen, Tianfeng Chen, Qinsong Zeng
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment
Natalia Georgantzoglou, Alexandros Pergaris, Christos Masaoutis, Stamatios Theocharis
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review
Leah H. Biller, Deborah Schrag
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Relationship between Bladder Cancer, Nutritional Supply, and Treatment Strategies: A Comprehensive Review
Fan Yang, Guanmo Liu, Jiaxin Wei, Yucheng Dong, Xuebin Zhang, Yongchang Zheng
NUTRIENTS (2023)
A systematic review on mutation markers for bladder cancer diagnosis in urine
Anouk E. Hentschel, Emma E. van der Toom, Andre N. Vis, Johannes C. F. Ket, Judith Bosschieter, Martijn W. Heymans, R. Jeroen A. van Moorselaar, Renske D. M. Steenbergen, Jakko A. Nieuwenhuijzen
BJU INTERNATIONAL (2021)
Precise diagnosis and treatment of non-muscle invasive bladder cancer - A clinical perspective
Yongjun Yang, Chen Wang, Zonglin Li, Qiang Lu, Yuanwei Li
FRONTIERS IN ONCOLOGY (2023)
State-of-the-Art Advances of Nanomedicine for Diagnosis and Treatment of Bladder Cancer
Chenfan Kong, Shaohua Zhang, Qifang Lei, Song Wu
BIOSENSORS-BASEL (2022)
Alternative splicing in bladder cancer: potential strategies for cancer diagnosis, prognosis, and treatment
Antonio J. Montero-Hidalgo, Jesus M. Perez-Gomez, Antonio J. Martinez-Fuentes, Enrique Gomez-Gomez, Manuel D. Gahete, Juan M. Jimenez-Vacas, Raul M. Luque
WILEY INTERDISCIPLINARY REVIEWS-RNA (2023)
Urinary Markers for Bladder Cancer Diagnosis and Monitoring
Seung-Hwan Jeong, Ja Hyeon Ku
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Exploiting volatile fingerprints for bladder cancer diagnosis: A scoping review of metabolomics and sensor-based approaches
Angela Carapito, Ana Cecilia A. Roque, Felix Carvalho, Joana Pinto, Paula Guedes de Pinho
TALANTA (2024)
Cancer cell detection device for the diagnosis of bladder cancer from urine
Melanie MacGregor, Hanieh Safizadeh Shirazi, Kit Man Chan, Kola Ostrikov, Kym McNicholas, Alex Jay, Michael Chong, Alexander H. Staudacher, Thomas D. Michl, Aigerim Zhalgasbaikyzy, Michael P. Brown, Moein Navvab Kashani, Adam Di Fiore, Alex Grochowski, Stephen Robb, Simon Belcher, Jordan Li, Jonathan M. Gleadle, Krasimir Vasilev
BIOSENSORS & BIOELECTRONICS (2021)
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review
Yanish Soorojebally, Yann Neuzillet, Mathieu Roumiguie, Pierre-Jean Lamy, Yves Allory, Francoise Descotes, Sophie Ferlicot, Diana Kassab-Chahmi, Stephane Oudard, Xavier Rebillard, Catherine Roy, Thierry Lebret, Morgan Roupret, Francois Audenet
WORLD JOURNAL OF UROLOGY (2023)
Advances in Diagnosis and Therapy for Bladder Cancer
Xinzi Hu, Guangzhi Li, Song Wu
CANCERS (2022)
Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
Mamello Sekhoacha, Keamogetswe Riet, Paballo Motloung, Lemohang Gumenku, Ayodeji Adegoke, Samson Mashele
MOLECULES (2022)
PTEN expression and morphological patterns in prostatic adenocarcinoma
Andrew J. Spieker, Jennifer B. Gordetsky, Alexander S. Maris, Lauren M. Dehan, James E. Denney, Shanna A. Arnold Egloff, Kristen Scarpato, Daniel A. Barocas, Giovanna A. Giannico
HISTOPATHOLOGY (2021)
Factors Associated With Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort
Lauren Folgosa Cooley, Adaeze A. Emeka, Travis J. Meyers
JOURNAL OF UROLOGY (2021)
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer
David D'Andrea, Peter C. Black, Homayoun Zargar, Colin P. Dinney, Francesco Soria, Michael S. Cookson, Jeffrey S. Montgomery, Wassim Kassouf, Marc A. Dall'Era, Srikala S. Sridhar, John S. McGrath, Jonathan L. Wright, Andrew C. Thorpe, Jeff M. Holzbeierlein, Diego M. Carrion, Ettore Di Trapani, Trinity J. Bivalacqua, Scott North, Daniel A. Barocas, Yair Lotan, Petros Grivas, Andrew J. Stephenson, Bas W. van Rhijn, Siamak Daneshmand, Philippe E. Spiess, Shahrokh F. Shariat, Kamran Zargar-Shoshtar, Laura S. Mertens, Adrian S. Fairey, Maria C. Mir, Laura-Maria Krabbe, Niels-Erik Jacobsen, Nikhil Vasdev, Evan Y. Yu, Evanguelos Xylinas, Benjamin Pradere, Renate Pichler, Nicholas J. Campain, Jo-An Seah, Cesar E. Ercole, Simon Horenblas, Jonathan Aning, Todd M. Morgan, Jay B. Shah, Marco Moschini
JOURNAL OF UROLOGY (2022)
Sexual function outcomes of radiation and androgen deprivation therapy for localized prostate cancer in men with good baseline function
Daniel D. Joyce, Christopher J. D. Wallis, Amy N. Luckenbaugh, Heather L. Huelster, Zhiguo Zhao, Karen E. Hoffman, Li-Ching Huang, Tatsuki Koyama, Ralph Conwill, Michael Goodman, Ann S. Hamilton, Xiao-Cheng Wu, Lisa E. Paddock, Antoinette Stroup, Matthew R. Cooperberg, Mia Hashibe, Brock B. O'Neil, Sherrie H. Kaplan, Sheldon Greenfield, David F. Penson, Daniel A. Barocas
PROSTATE CANCER AND PROSTATIC DISEASES (2022)
Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: An assessment of the comparative effectiveness analysis of surgery and radiation (CEASAR) cohort
Christopher J. D. Wallis, Li-Ching Huang, Zhiguo Zhao, David F. Penson, Tatsuki Koyama, Ralph Conwill, Jacob E. Tallman, Michael Goodman, Ann S. Hamilton, Xiao-Cheng Wu, Lisa E. Paddock, Antoinette Stroup, Matthew R. Cooperberg, Mia Hashibe, Brock B. O'Neil, Sherrie H. Kaplan, Sheldon Greenfield, Daniel A. Barocas, Karen E. Hoffman
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)
Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes
Amy N. Luckenbaugh, Christopher J. D. Wallis, Li-Ching Huang, Daniela Wittmann, Zachary Klaassen, Zighuo Zhao, Tatsuki Koyama, Aaron A. Laviana, Ralph Conwill, Michael Goodman, Ann S. Hamilton, Xiao-Cheng Wu, Lisa E. Paddock, Antoinette Stroup, Matthew R. Cooperberg, Mia Hashibe, Brock B. O'Neil, Sherrie H. Kaplan, Sheldon Greenfield, Karen E. Hoffman, David F. Penson, Daniel A. Barocas
JOURNAL OF UROLOGY (2022)
Association Between Surgical Volume and Survival Among Patients With Variant Histologies of Bladder Cancer
Wilson Sui, Mary E. Hall, Daniel A. Barocas, Sam S. Chang, Amy N. Luckenbaugh, Kelvin A. Moses, David F. Penson, Christopher J. D. Wallis, Aaron A. Laviana
UROLOGY (2022)
Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer
Christopher J. D. Wallis, Zhiguo Zhao, Li-Ching Huang, David F. Penson, Tatsuki Koyama, Sherrie H. Kaplan, Sheldon Greenfield, Amy N. Luckenbaugh, Zachary Klaassen, Ralph Conwill, Michael Goodman, Ann S. Hamilton, Xiao-Cheng Wu, Lisa E. Paddock, Antoinette Stroup, Matthew R. Cooperberg, Mia Hashibe, Brock B. O'Neil, Karen E. Hoffman, Daniel A. Barocas
JAMA ONCOLOGY (2022)
Comparison of Robot-Assisted and Open Radical Cystectomy in Recovery of Patient-Reported and Performance-Related Measures of Independence A Secondary Analysis of a Randomized Clinical Trial
Vivek Venkatramani, Isildinha M. Reis, Mark L. Gonzalgo, Erik P. Castle, Michael E. Woods, Robert S. Svatek, Alon Z. Weizer, Badrinath R. Konety, Mathew Tollefson, Tracey L. Krupski, Norm D. Smith, Ahmad Shabsigh, Daniel A. Barocas, Marcus L. Quek, Atreya Dash, Dipen J. Parekh
JAMA NETWORK OPEN (2022)
Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium (vol 7, pg 1347, 2021)
Maria Carmen Mir, Michele Marchionic, Homi Zargard, K. Zargar-Shoshtari, A. S. Fairey, Laura S. Mertens, C. P. Dinney, L. M. Krabbei, M. S. Cookson, N. E. Jacobsen, J. Griffin, J. S. Montgomery, N. Vasdev, E. Y. Yu, E. Xylinas, J. S. McGrathr, W. Kassoufs, M. A. Dall'Era, S. S. Sridhar, J. Aningn, S. F. Shariat, J. L. Wright, A. C. Thorpe, T. M. Morganm, J. M. Holzbeierlein, T. J. Bivalacquax, S. North, D. A. Barocas, Y. Lotan, P. Grivaso, A. J. Stephenson, J. B. Shah, B. W. van Rhijng, P. E. Spiess, S. Daneshmand, P. C. Blackd
EUROPEAN UROLOGY FOCUS (2022)
Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer
Jacob E. Tallman, Christopher J. D. Wallis, Li-Ching Huang, Zhiguo Zhao, David F. Penson, Tatsuki Koyama, Ralph Conwill, Michael Goodman, Ann S. Hamilton, Xiao-Cheng Wu, Lisa E. Paddock, Antoinette Stroup, Matthew R. Cooperberg, Mia Hashibe, Brock B. O'Neil, Sherrie H. Kaplan, Sheldon Greenfield, Daniel A. Barocas, Karen E. Hoffman
PROSTATE CANCER AND PROSTATIC DISEASES (2023)
Projected Savings for Generic Oncology Drugs Purchased via Mark Cuban Cost Plus Drug Company Versus in Medicare
Brian D. Cortese, Stacie B. Dusetzina, Amy N. Luckenbaugh, Bashir Al Hussein Al Awamlh, C. J. Stimson, Daniel A. Barocas, David F. Penson, Sam S. Chang, Ruchika Talwar
JOURNAL OF CLINICAL ONCOLOGY (2023)
Genetic factors associated with prostate cancer conversion from active surveillance to treatment
Yu Jiang, Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki, Irene Helenowski, Linda Kachuri, Daniel W. Lin, Janet L. Stanford, Lisa F. Newcomb, Suzanne Kolb, Antonio Finelli, Neil E. Fleshner, Maria Komisarenko, James A. Eastham, Behfar Ehdaie, Nicole Benfante, Christopher J. Logothetis, Justin R. Gregg, Cherie A. Perez, Sergio Garza, Jeri Kim, Leonard S. Marks, Merdie Delfin, Danielle Barsa, Danny Vesprini, Laurence H. Klotz, Andrew Loblaw, Alexandre Mamedov, S. Larry Goldenberg, Celestia S. Higano, Maria Spillane, Eugenia Wu, H. Ballentine Carter, Christian P. Pavlovich, Mufaddal Mamawala, Tricia Landis, Peter R. Carroll, June M. Chan, Matthew R. Cooperberg, Janet E. Cowan, Todd M. Morgan, Javed Siddiqui, Rabia Martin, Eric A. Klein, Karen Brittain, Paige Gotwald, Daniel A. Barocas, Jeremiah R. Dallmer, Jennifer B. Gordetsky, Pam Steele, Shilajit D. Kundu, Jazmine Stockdale, Monique J. Roobol, Lionne D. F. Venderbos, Martin G. Sanda, Rebecca Arnold, Dattatraya Patil, Christopher P. Evans, Marc A. Dall'Era, Anjali Vij, Anthony J. Costello, Ken Chow, Niall M. Corcoran, Soroush Rais-Bahrami, Courtney Phares, Douglas S. Scherr, Thomas Flynn, R. Jeffrey Karnes, Michael Koch, Courtney Rose Dhondt, Joel B. Nelson, Dawn McBride, Michael S. Cookson, Kelly L. Stratton, Stephen Farriester, Erin Hemken, Walter M. Stadler, Tuula Pera, Deimante Banionyte, Fernando J. Bianco, Isabel H. Lopez, Stacy Loeb, Samir S. Taneja, Nataliya Byrne, Christopher L. Amling, Ann Martinez, Luc Boileau, Franklin D. Gaylis, Jacqueline Petkewicz, Nicholas Kirwen, Brian T. Helfand, Jianfeng Xu, Denise M. Scholtens, William J. Catalona, John S. Witte
HUMAN GENETICS AND GENOMICS ADVANCES (2022)
Comment on Responsibilities and Expectations: Considerations of Disclosure of Overlapping Operations
Benjamin V. Stone, David Feng, Zachary Klaassen, Daniel A. Barocas, Christopher J. D. Wallis
ANNALS OF SURGERY (2021)
Differential effect of body mass index by gender on oncological outcomes in patients with renal cell carcinoma
Melih Balci, Zachary A. Glaser, Sam S. Chang, S. Duke Herrell, Daniel A. Barocas, Kirk A. Keegan, Kelvin A. Moses, Matthew J. Resnick, Joseph A. Smith, David F. Penson, Kristen Scarpato, Peter E. Clark
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2021)